AI-Designed Antibodies Achieve Breakthroughs in Drug Development and Protein Design
TL;DR
Researchers from Nobel Laureate David Baker's lab and the University of Washington have used AI to design antibodies from scratch, successfully creating molecules that bind to their targets, potentially revolutionizing the antibody drug industry and enabling faster, more efficient drug development.
Topics:businessscience#ai-designed-antibodies#antibody-engineering#biotechnology#nobel-laureate-david-baker#protein-design#science
- Nobel winner’s lab notches another breakthrough: AI-designed antibodies that hit their targets GeekWire
- Atomically accurate de novo design of antibodies with RFdiffusion Nature
- AI-designed antibodies promise big boost to drug development Financial Times
- ‘Not the end of the story:’ Nobel laureate David Baker on what’s next for de novo design after RFantibody lands in Nature Endpoints News
- Academic AIs make inroads in protein binder design Chemical & Engineering News
Want the full story? Read the original reporting
Read on GeekWire